Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 22 | 2020 | 322 | 5.030 |
Why?
|
| Electrocardiography | 19 | 2020 | 604 | 2.100 |
Why?
|
| Heart Conduction System | 6 | 2018 | 72 | 1.660 |
Why?
|
| Catheter Ablation | 5 | 2017 | 67 | 1.370 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2020 | 89 | 1.260 |
Why?
|
| Heart Failure | 5 | 2020 | 639 | 1.200 |
Why?
|
| Pacemaker, Artificial | 5 | 2019 | 19 | 1.140 |
Why?
|
| Atrial Appendage | 2 | 2017 | 10 | 1.080 |
Why?
|
| Myocardial Infarction | 8 | 2017 | 473 | 1.060 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2017 | 73 | 1.040 |
Why?
|
| Postoperative Complications | 3 | 2015 | 780 | 0.910 |
Why?
|
| Anticoagulants | 4 | 2017 | 122 | 0.850 |
Why?
|
| Humans | 52 | 2020 | 32082 | 0.790 |
Why?
|
| Male | 42 | 2020 | 19202 | 0.760 |
Why?
|
| Heart-Assist Devices | 1 | 2020 | 25 | 0.700 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2020 | 10 | 0.680 |
Why?
|
| Middle Aged | 32 | 2020 | 11834 | 0.660 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2016 | 9 | 0.660 |
Why?
|
| Mercury | 1 | 2018 | 6 | 0.650 |
Why?
|
| Environmental Pollution | 1 | 2018 | 5 | 0.650 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 4 | 0.650 |
Why?
|
| Female | 38 | 2020 | 19999 | 0.640 |
Why?
|
| Environmental Monitoring | 1 | 2018 | 28 | 0.640 |
Why?
|
| Risk Factors | 21 | 2020 | 3880 | 0.640 |
Why?
|
| Heart Ventricles | 4 | 2018 | 135 | 0.620 |
Why?
|
| Hyperkalemia | 1 | 2018 | 15 | 0.620 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 18 | 0.610 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2017 | 24 | 0.600 |
Why?
|
| Aged | 27 | 2020 | 10308 | 0.600 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 5 | 0.580 |
Why?
|
| Intracranial Embolism | 1 | 2017 | 12 | 0.580 |
Why?
|
| Heart Valve Prosthesis | 1 | 2017 | 55 | 0.580 |
Why?
|
| Denervation | 1 | 2017 | 12 | 0.580 |
Why?
|
| Ventricular Premature Complexes | 1 | 2017 | 13 | 0.570 |
Why?
|
| Electric Countershock | 2 | 2013 | 11 | 0.550 |
Why?
|
| Healthcare Disparities | 2 | 2015 | 169 | 0.530 |
Why?
|
| Treatment Outcome | 13 | 2017 | 3304 | 0.510 |
Why?
|
| Stroke | 6 | 2017 | 584 | 0.510 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 917 | 0.510 |
Why?
|
| Retrospective Studies | 18 | 2020 | 3505 | 0.510 |
Why?
|
| Defibrillators, Implantable | 4 | 2019 | 17 | 0.510 |
Why?
|
| Hospitalization | 4 | 2017 | 468 | 0.500 |
Why?
|
| Thromboembolism | 1 | 2015 | 34 | 0.500 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2014 | 3 | 0.500 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 42 | 0.490 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2015 | 170 | 0.470 |
Why?
|
| Incidence | 7 | 2020 | 1199 | 0.470 |
Why?
|
| Coffee | 1 | 2013 | 8 | 0.460 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2013 | 1 | 0.450 |
Why?
|
| Caffeine | 1 | 2013 | 29 | 0.450 |
Why?
|
| Cardiac Output, High | 1 | 2012 | 2 | 0.430 |
Why?
|
| Iliac Vein | 1 | 2012 | 8 | 0.430 |
Why?
|
| Arteriovenous Fistula | 1 | 2012 | 18 | 0.420 |
Why?
|
| Respiration, Artificial | 1 | 2013 | 98 | 0.420 |
Why?
|
| United States | 12 | 2020 | 3975 | 0.420 |
Why?
|
| Iliac Artery | 1 | 2012 | 49 | 0.420 |
Why?
|
| Warfarin | 3 | 2017 | 29 | 0.420 |
Why?
|
| Early Diagnosis | 1 | 2011 | 62 | 0.390 |
Why?
|
| Angina Pectoris | 1 | 2011 | 22 | 0.390 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 30 | 0.380 |
Why?
|
| Aged, 80 and over | 12 | 2017 | 3990 | 0.380 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 145 | 0.380 |
Why?
|
| Atrial Flutter | 3 | 2016 | 14 | 0.350 |
Why?
|
| Stents | 1 | 2011 | 177 | 0.350 |
Why?
|
| Chest Pain | 2 | 2011 | 205 | 0.330 |
Why?
|
| Health Status | 1 | 2011 | 400 | 0.330 |
Why?
|
| European Continental Ancestry Group | 4 | 2019 | 1165 | 0.330 |
Why?
|
| Surgical Procedures, Operative | 3 | 2014 | 84 | 0.320 |
Why?
|
| Keratitis | 1 | 2008 | 3 | 0.320 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2008 | 9 | 0.320 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 31 | 0.310 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 40 | 0.310 |
Why?
|
| Medicare | 3 | 2019 | 206 | 0.290 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 516 | 0.280 |
Why?
|
| Time Factors | 9 | 2020 | 2145 | 0.280 |
Why?
|
| Risk Assessment | 8 | 2020 | 1427 | 0.280 |
Why?
|
| Brain Ischemia | 2 | 2019 | 146 | 0.270 |
Why?
|
| African Americans | 4 | 2019 | 1424 | 0.270 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 753 | 0.240 |
Why?
|
| Bundle-Branch Block | 2 | 2015 | 19 | 0.230 |
Why?
|
| Sex Factors | 5 | 2017 | 667 | 0.230 |
Why?
|
| Stroke Volume | 3 | 2018 | 348 | 0.230 |
Why?
|
| Comorbidity | 3 | 2020 | 566 | 0.220 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 684 | 0.220 |
Why?
|
| Confidence Intervals | 3 | 2012 | 149 | 0.220 |
Why?
|
| Dyspnea | 2 | 2014 | 33 | 0.220 |
Why?
|
| Cohort Studies | 5 | 2020 | 1816 | 0.220 |
Why?
|
| HIV Infections | 1 | 2008 | 395 | 0.220 |
Why?
|
| Hypertension | 2 | 2020 | 961 | 0.210 |
Why?
|
| Patient Readmission | 2 | 2015 | 126 | 0.210 |
Why?
|
| Prognosis | 2 | 2020 | 1496 | 0.200 |
Why?
|
| Age of Onset | 2 | 2013 | 94 | 0.200 |
Why?
|
| Emergency Treatment | 2 | 2012 | 42 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1428 | 0.200 |
Why?
|
| Heart Atria | 2 | 2020 | 65 | 0.190 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 770 | 0.190 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 43 | 0.180 |
Why?
|
| Atrial Premature Complexes | 1 | 2020 | 16 | 0.170 |
Why?
|
| Adult | 10 | 2017 | 9375 | 0.170 |
Why?
|
| Hemodynamics | 1 | 2020 | 155 | 0.170 |
Why?
|
| Cause of Death | 3 | 2018 | 236 | 0.160 |
Why?
|
| Fossil Fuels | 1 | 2018 | 1 | 0.160 |
Why?
|
| Mining | 1 | 2018 | 1 | 0.160 |
Why?
|
| Rivers | 1 | 2018 | 4 | 0.160 |
Why?
|
| Metals, Heavy | 1 | 2018 | 7 | 0.160 |
Why?
|
| India | 1 | 2018 | 61 | 0.160 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 58 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 255 | 0.150 |
Why?
|
| Pulmonary Veins | 1 | 2017 | 10 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 2263 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 245 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 56 | 0.140 |
Why?
|
| Odds Ratio | 3 | 2012 | 472 | 0.140 |
Why?
|
| Echocardiography | 2 | 2018 | 158 | 0.130 |
Why?
|
| Brachiocephalic Veins | 1 | 2015 | 8 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 40 | 0.130 |
Why?
|
| Subclavian Vein | 1 | 2015 | 16 | 0.130 |
Why?
|
| Heart Septum | 1 | 2015 | 2 | 0.120 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 297 | 0.120 |
Why?
|
| Dizziness | 1 | 2014 | 12 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2015 | 66 | 0.120 |
Why?
|
| Health Status Disparities | 1 | 2016 | 131 | 0.120 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2012 | 120 | 0.120 |
Why?
|
| Coronary Angiography | 2 | 2012 | 153 | 0.120 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 62 | 0.110 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2013 | 2 | 0.110 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2013 | 5 | 0.110 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2012 | 1 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2012 | 378 | 0.110 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2012 | 4 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2012 | 14 | 0.110 |
Why?
|
| Edema | 1 | 2012 | 28 | 0.110 |
Why?
|
| Kidney | 1 | 2017 | 518 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2012 | 30 | 0.110 |
Why?
|
| Erythema | 1 | 2012 | 26 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 99 | 0.100 |
Why?
|
| Bacteremia | 1 | 2012 | 65 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 44 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 85 | 0.100 |
Why?
|
| Hispanic Americans | 2 | 2015 | 940 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2012 | 467 | 0.100 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2011 | 8 | 0.100 |
Why?
|
| Physical Exertion | 1 | 2011 | 13 | 0.100 |
Why?
|
| Radiography | 1 | 2012 | 374 | 0.100 |
Why?
|
| Sympathomimetics | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 12 | 0.100 |
Why?
|
| Methamphetamine | 1 | 2011 | 17 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2011 | 59 | 0.090 |
Why?
|
| Continental Population Groups | 1 | 2012 | 237 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 49 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 873 | 0.090 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2010 | 1 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 242 | 0.090 |
Why?
|
| Lymphoma, T-Cell | 1 | 2010 | 3 | 0.090 |
Why?
|
| Heart Rupture | 1 | 2010 | 3 | 0.090 |
Why?
|
| Disease Progression | 1 | 2011 | 594 | 0.080 |
Why?
|
| Young Adult | 2 | 2017 | 2665 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 57 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 581 | 0.070 |
Why?
|
| Propensity Score | 2 | 2017 | 39 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 765 | 0.070 |
Why?
|
| Patient Admission | 2 | 2017 | 58 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2017 | 187 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2017 | 354 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2020 | 846 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 322 | 0.060 |
Why?
|
| Depression | 1 | 2009 | 445 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 401 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 783 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2015 | 97 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 2282 | 0.050 |
Why?
|
| Registries | 2 | 2012 | 298 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2011 | 83 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 881 | 0.050 |
Why?
|
| Heart Rate | 1 | 2020 | 335 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 494 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2017 | 8 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 25 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2017 | 100 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 876 | 0.030 |
Why?
|
| Iowa | 1 | 2015 | 9 | 0.030 |
Why?
|
| Phlebography | 1 | 2015 | 26 | 0.030 |
Why?
|
| Ventricular Septum | 1 | 2015 | 1 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 46 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 105 | 0.030 |
Why?
|
| California | 1 | 2013 | 63 | 0.030 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 12 | 0.030 |
Why?
|
| San Francisco | 1 | 2012 | 4 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2012 | 10 | 0.030 |
Why?
|
| Cineradiography | 1 | 2012 | 1 | 0.030 |
Why?
|
| Safety-Based Medical Device Withdrawals | 1 | 2012 | 1 | 0.030 |
Why?
|
| Endocardium | 1 | 2012 | 3 | 0.030 |
Why?
|
| Ambulances | 1 | 2012 | 13 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 163 | 0.030 |
Why?
|
| Troponin I | 1 | 2012 | 22 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2012 | 29 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2012 | 37 | 0.030 |
Why?
|
| Device Removal | 1 | 2012 | 32 | 0.030 |
Why?
|
| Telemedicine | 1 | 2013 | 102 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 1187 | 0.030 |
Why?
|
| Running | 1 | 2011 | 19 | 0.020 |
Why?
|
| Physicians | 1 | 2013 | 159 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 448 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 462 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 128 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 315 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 35 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 177 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 38 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 989 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 190 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 3568 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1542 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 308 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 414 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 765 | 0.020 |
Why?
|